4.3 Article

Quality of life and mental health in multiple sclerosis patients during the COVID-19 Pandemic

Related references

Note: Only part of the references are listed.
Article Immunology

The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States

Don Bambino Geno Tai et al.

Summary: The COVID-19 pandemic has disproportionately affected minority groups like African American, Native American, and LatinX communities with higher death rates. These disparities may be caused by biomedical factors and social determinants of health. Minority groups are more likely to have chronic medical conditions and lower access to healthcare, leading to worse COVID-19 outcomes.

CLINICAL INFECTIOUS DISEASES (2021)

Article Neurosciences

Mental Health Issues During and After COVID-19 Vaccine Era

Kabita Pandey et al.

Summary: The COVID-19 pandemic has lasting impacts on neurological complications and mental health, with evidence of acute symptoms such as neuroinflammation and cognitive impairment. Despite widespread vaccine distribution, hesitancy persists, and social determinants play a crucial role in mental health outcomes, particularly for disadvantaged populations during crises.

BRAIN RESEARCH BULLETIN (2021)

Article Health Policy & Services

Social Determinants of Mental Health as Mediators and Moderators of the Mental Health Impacts of the COVID-19 Pandemic

Francesco Bernardini et al.

Summary: The impacts of the COVID-19 pandemic are significantly influenced by social determinants of health, particularly in terms of infection and mortality rates among minority and vulnerable populations. The economic repercussions of containment measures have had cascading effects that will impact mental health in the years to come.

PSYCHIATRIC SERVICES (2021)

Editorial Material Clinical Neurology

Editorial: Consequences of the COVID-19 Pandemic on Care for Neurological Conditions

Jordi A. Matias-Guiu et al.

FRONTIERS IN NEUROLOGY (2021)

Article Rheumatology

Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases

Javier Bachiller-Corral et al.

Summary: The study found that patients with inflammatory rheumatic diseases accounted for 1.8% of the total hospitalized population. Patients with diseases such as rheumatoid arthritis, vasculitis, and systemic lupus erythematosus had a higher risk of hospitalization. Rheumatoid arthritis patients also showed a higher mortality rate in COVID-19, especially those treated with RTX.

JOURNAL OF RHEUMATOLOGY (2021)

Article Public, Environmental & Occupational Health

Characteristics and outcomes of Hispanic/Latinx patients with coronavirus disease 19 (COVID-19) requiring hospitalization in Rhode Island: a retrospective cohort study

Raul Macias Gil et al.

Summary: The study found that Hispanic patients hospitalized with COVID-19 were younger compared to non-Hispanic Whites, and those over 65 years old were more likely to experience more severe outcomes such as ICU admission and intubation. Further research is needed to address health disparities in Hispanic and other vulnerable populations in the context of COVID-19 and future pandemics.

ANNALS OF EPIDEMIOLOGY (2021)

Article Clinical Neurology

The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the Neutral

Hannah Morris-Bankole et al.

Summary: The study found that COVID-19 had a neutral impact on 48% of participants, a positive impact on 16%, and a negative impact on 36%. Age, type of MS, and presence of psychological symptoms were significant predictors of negative impact.

NEUROLOGY AND THERAPY (2021)

Article Multidisciplinary Sciences

Cell entry mechanisms of SARS-CoV-2

Jian Shang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Clinical Neurology

Multiple sclerosis management during the COVID-19 pandemic

Brandon P. Moss et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Review Psychiatry

PUBLIC MENTAL HEALTH IN POST-COVID-19 ERA

Fei-Fei Ren et al.

PSYCHIATRIA DANUBINA (2020)

Review Clinical Neurology

Identifying risk factors for cognitive issues in multiple sclerosis

Maria Pia Amato et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)

Article Clinical Neurology

Revisiting cognitive reserve and cognition in multiple sclerosis: A closer look at depression

Viral P. Patel et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Article Clinical Neurology

Revisiting cognitive reserve and cognition in multiple sclerosis: A closer look at depression

Viral P. Patel et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Review Clinical Neurology

Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis

Rosa E. Boeschoten et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Review Clinical Neurology

A systematic review of anxiety amongst people with Multiple Sclerosis

Ellen Butler et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)

Review Clinical Neurology

The link between multiple sclerosis and depression

Anthony Feinstein et al.

NATURE REVIEWS NEUROLOGY (2014)

Review Psychology, Clinical

Multiple sclerosis: Empirical literature for the clinical health psychologist

DC Mohr et al.

JOURNAL OF CLINICAL PSYCHOLOGY (2001)